Toward a Diagnostic Score in Cushing's Syndrome
- PMID: 31787931
- PMCID: PMC6856055
- DOI: 10.3389/fendo.2019.00766
Toward a Diagnostic Score in Cushing's Syndrome
Abstract
Cushing's syndrome (CS) is a classical rare disease: it is often suspected in patients who do not have the disease; at the same time, it takes a mean of 3 years to diagnose CS in affected individuals. The main reason is the extreme rarity (1-3/million/year) in combination with the lack of a single lead symptom. CS has to be suspected when a combination of signs and symptoms is present, which together make up the characteristic phenotype of cortisol excess. Unusual fat distribution affecting the face, neck, and trunk; skin changes including plethora, acne, hirsutism, livid striae, and easy bruising; and signs of protein catabolism such as thinned and vulnerable skin, osteoporotic fractures, and proximal myopathy indicate the need for biochemical screening for CS. In contrast, common symptoms like hypertension, weight gain, or diabetes also occur quite frequently in the general population and per se do not justify biochemical testing. First-line screening tests include urinary free cortisol excretion, dexamethasone suppression testing, and late-night salivary cortisol measurements. All three tests have overall reasonable sensitivity and specificity, and first-line testing should be selected on the basis of the physiologic conditions of the patient, drug intake, and available laboratory quality control measures. Two normal test results usually exclude the presence of CS. Other tests and laboratory parameters like the high-dose dexamethasone suppression test, plasma ACTH, the CRH test, and the bilateral inferior petrosal sinus sampling are not part of the initial biochemical screening. As a general rule, biochemical screening should only be performed if the pre-test probability for CS is reasonably high. This article provides an overview about the current standard in the diagnosis of CS starting with clinical scores and screenings, the clinical signs, relevant differential diagnoses, the first-line biochemical screening, and ending with a few exceptional cases.
Keywords: Cushing's disease; Cushing's syndrome; diagnostic score; hypercortisolism; low-dose-dexamethasone-suppression-test; urine cortisol.
Copyright © 2019 Braun, Riester, Oßwald-Kopp, Fazel, Rubinstein, Bidlingmaier, Beuschlein and Reincke.
Similar articles
-
Cushing's Syndrome: Screening and Diagnosis.High Blood Press Cardiovasc Prev. 2016 Sep;23(3):209-15. doi: 10.1007/s40292-016-0153-4. Epub 2016 May 9. High Blood Press Cardiovasc Prev. 2016. PMID: 27160717 Review.
-
Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.J Clin Endocrinol Metab. 1997 Jun;82(6):1780-5. doi: 10.1210/jcem.82.6.3991. J Clin Endocrinol Metab. 1997. PMID: 9177382
-
Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.JAMA. 1993 May 5;269(17):2232-8. JAMA. 1993. PMID: 8386285
-
Pitfalls in the diagnosis and management of Cushing's syndrome.Neurosurg Focus. 2015 Feb;38(2):E4. doi: 10.3171/2014.11.FOCUS14704. Neurosurg Focus. 2015. PMID: 25639322 Review.
-
[Cushing's syndrome: diagnostic exploration].Presse Med. 1994 Jan 8-15;23(1):43-8. Presse Med. 1994. PMID: 8127815 Review. French.
Cited by
-
Current Challenges and Future Directions in the Assessment of Glucocorticoid Status.Endocr Rev. 2024 Nov 22;45(6):795-817. doi: 10.1210/endrev/bnae016. Endocr Rev. 2024. PMID: 38795365 Free PMC article. Review.
-
Editorial: A year in review: discussions in adrenal endocrinology.Front Endocrinol (Lausanne). 2023 Sep 22;14:1291582. doi: 10.3389/fendo.2023.1291582. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37810878 Free PMC article. No abstract available.
-
PPARG dysregulation as a potential molecular target in adrenal Cushing's syndrome.Front Endocrinol (Lausanne). 2023 Nov 30;14:1265794. doi: 10.3389/fendo.2023.1265794. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38098864 Free PMC article.
-
Persisting Muscle Dysfunction in Cushing's Syndrome Despite Biochemical Remission.J Clin Endocrinol Metab. 2020 Dec 1;105(12):e4490-8. doi: 10.1210/clinem/dgaa625. J Clin Endocrinol Metab. 2020. PMID: 32882010 Free PMC article.
-
Proximal muscle weakness as the sole manifestation of Cushing's disease, misdiagnosed as dermatomyositis: a case report.J Med Case Rep. 2022 Dec 22;16(1):483. doi: 10.1186/s13256-022-03649-4. J Med Case Rep. 2022. PMID: 36544169 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials